Cite

HARVARD Citation

    Flippot, R. et al. (n.d.). 868PDBrain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial. Annals of oncology. p. . [Online]. 
  
Back to record